-
1.发明申请公开(公告)号：US20190250171A1
公开(公告)日：2019-08-15
申请号：US16211006
申请日：2018-12-05
Inventor： Michael SIERKS , Stephanie WILLIAMS , Lalitha VENKATARAMAN
CPC classification number: G01N33/6896 , C07K16/18 , C07K2317/622 , G01N2800/2814 , G01N2800/285
Abstract: The invention relates to antibodies, antibody fragments and binding agents that specifically recognize TDP-43 associated with frontotemporal dementia (FTD), but not TDP-43 associated with amyotrophic lateral sclerosis (ALS) or TDP-43 associated with healthy human brain tissue, and antibodies, antibody fragments and binding agents that specifically recognize TDP-43 associated with ALS, but not TDP-43 associated FTD or TDP-43 associated with healthy human brain tissue.
-
公开(公告)号：US20200278358A1
公开(公告)日：2020-09-03
申请号：US16588481
申请日：2019-09-30
Inventor： Michael SIERKS , Stephanie WILLIAMS
IPC: G01N33/68
Abstract: The invention provides diagnostic tests to distinguish between different pre-symptomatic neurodegenerative diseases.
-
Patent Agency Ranking
公开(公告)号：US20190195892A1
公开(公告)日：2019-06-27
申请号：US16121481
申请日：2018-09-04
Inventor： Michael SIERKS , Stephanie WILLIAMS
IPC: G01N33/68
CPC classification number: G01N33/6896 , G01N2333/005 , G01N2333/4709 , G01N2800/28 , G01N2800/2821 , G01N2800/2835 , G01N2800/50
Abstract: The invention provides diagnostic tests to distinguish between different pre-symptomatic neurodegenerative diseases.
-
公开(公告)号：US20220221795A1
公开(公告)日：2022-07-14
申请号：US17499777
申请日：2021-10-12
Inventor： Michael SIERKS , Stephanie WILLIAMS
Abstract: The present invention provides detection reagents and method for determining risk of traumatic brain injury (TBI), assessment of the amount of neuronal damage, and/or susceptibility to neurodegenerative disease in a subject.
-
5.发明申请ANTIBODY BASED REAGENTS THAT SPECIFICALLY RECOGNIZE NEURODEGENERATIVE DISEASE RELATED FORMS OF THE PROTEIN TDP-43 审中-公开抗体基因型特异性识别蛋白TDP-43相关表型的神经细胞病公开(公告)号：US20170010284A1
公开(公告)日：2017-01-12
申请号：US15114356
申请日：2015-02-02
Inventor： Michael SIERKS , Stephanie WILLIAMS , Lalitha VENKATARAMAN
CPC classification number: G01N33/6896 , C07K16/18 , C07K2317/622 , G01N2800/2814 , G01N2800/285
Abstract: The invention relates to antibodies, antibody fragments and binding agents that specifically recognize TDP-43 associated with frontotemporal dementia (FTD), but not TDP-43 associated with amyotrophic lateral sclerosis (ALS) or TDP-43 associated with healthy human brain tissue, and antibodies, antibody fragments and binding agents that specifically recognize TDP-43 associated with ALS, but not TDP-43 associated FTD or TDP-43 associated with healthy human brain tissue.
Abstract translation: 本发明涉及特异性识别与额颞叶痴呆（FTD）相关的TDP-43但与健康人脑组织相关的肌萎缩性侧索硬化（ALS）或TDP-43相关的TDP-43的抗体，抗体片段和结合剂，以及 抗体，抗体片段和特异性识别与健康人类脑组织相关的与ALS相关的TDP-43而不与TDP-43相关联的FTD或TDP-43的结合剂。
-
公开(公告)号：US20210373036A1
公开(公告)日：2021-12-02
申请号：US17242780
申请日：2021-04-28
Inventor： Michael SIERKS , Stephanie WILLIAMS , Lalitha VENKATARAMAN
Abstract: The invention relates to antibodies, antibody fragments and binding agents that specifically recognize TDP-43 associated with frontotemporal dementia (FTD), but not TDP-43 associated with amyotrophic lateral sclerosis (ALS) or TDP-43 associated with healthy human brain tissue, and antibodies, antibody fragments and binding agents that specifically recognize TDP-43 associated with ALS, but not TDP-43 associated FTD or TDP-43 associated with healthy human brain tissue.
-
7.发明申请公开(公告)号：US20160320412A1
公开(公告)日：2016-11-03
申请号：US15107815
申请日：2014-11-24
Inventor： Michael SIERKS , Stephanie WILLIAMS
IPC: G01N33/68
CPC classification number: G01N33/6896 , G01N2333/005 , G01N2333/4709 , G01N2800/28 , G01N2800/2821 , G01N2800/2835 , G01N2800/50
Abstract: The invention provides diagnostic tests to distinguish between different pre-symptomatic neurodegenerative diseases.
Abstract translation: 本发明提供诊断测试以区分不同的症状前症状的神经变性疾病。
-
-
-
-
-
-
Search Results
7
records
(took 0.021 seconds)
